A sensitive, selective and reproducible high-performance liquid chromatographic assay for the simultaneous determination of metoprolol and alpha-hydroxymetoprolol in plasma was developed with (+/-)-ethyl-2-(4-(3-isopropyl-amino-2-hydroxy-propoxy)phenyl)-ethyl carbamate as the internal standard. Samples were acidified and subjected to an organic wash to remove interfering neutral and acidic components. Final extraction is made from the alkalinized aqueous phase with methylene chloride. The samples were chromatographed on a microparticulate silica gel column with fluorescent detection. Sensitivity was 3 ng/ml for metoprolol and 12.5 ng/ml for alpha-hydroxymetoprolol. Specificity was established by comparison of retention times of samples with standard materials. A typical absorption/disposition profile for metoprolol and alpha-hydroxymetoprolol is presented for one subject who received 50 mg of metoprolol tartrate (Lopressor).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0378-4347(00)80434-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Analysis of serum concentrations of metoprolol and its metabolite α-hydroxymetoprolol in patients with heart failure with reduced ejection fraction: a pilot study in routine health care.
Expert Rev Clin Pharmacol
January 2025
Department of Internal Medicine and Cardiology, University Hospital Ostrava, Ostrava, Czech Republic.
Background: The cardioselective β-1 receptor antagonist metoprolol is used to treat heart failure. It is metabolized in the liver, primarily by cytochrome 2D6.
Research Design And Methods: In this study, trough serum concentrations of metoprolol and its metabolite α-hydroxymetoprolol were measured in patients with heart failure with reduced ejection fraction.
Study on genotype and phenotype of novel CYP2D6 variants using pharmacokinetic and pharmacodynamic models with metoprolol as a substrate drug.
Pharmacogenomics J
April 2024
Institute of Molecular Toxicology and Pharmacology, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Article Synopsis
- A study was conducted on 22 volunteers to explore how different CYP2D6 gene variants affect the metabolism of the drug metoprolol, using blood and urine samples after oral administration.
- Results showed that individuals with certain genotypes (CYP2D6*10/*87, CYP2D6*10/*95, CYP2D6*97/*97) metabolized metoprolol much more slowly, with a 2-3 times increase in drug exposure compared to typical metabolizers (CYP2D6*1/*1 and CYP2D6*1/*34).
- While blood concentration was linked to these gene variations, the study found that the maximum blood pressure-lowering effect of met
The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis.
Clin Pharmacokinet
August 2023
Division of Clinical Pharmacology and Toxicology, University Hospital Basel, 4031, Basel, Switzerland.
Background And Objective: The impact of liver cirrhosis on the activity of UDP-glucuronosyltransferases (UGTs) is currently not well characterized. We investigated the glucuronidation capacity and glucuronide accumulation in patients with liver cirrhosis.
Methods: We administered the Basel phenotyping cocktail (caffeine, efavirenz, flurbiprofen, omeprazole, metoprolol, midazolam) to patients with liver cirrhosis (n = 16 Child A, n = 15 Child B, n = 5 Child C) and n = 12 control subjects and obtained pharmacokinetic profiles of substrates and primary metabolites and their glucuronides.
Liver Cirrhosis Affects the Pharmacokinetics of the Six Substrates of the Basel Phenotyping Cocktail Differently.
Clin Pharmacokinet
July 2022
Division of Clinical Pharmacology and Toxicology, University Hospital Basel, 4031, Basel, Switzerland.
Background: Activities of hepatic cytochrome P450 enzymes (CYPs) are relevant for hepatic clearance of drugs and known to be decreased in patients with liver cirrhosis. Several studies have reported the effect of liver cirrhosis on CYP activity, but the results are partially conflicting and for some CYPs lacking.
Objective: In this study, we aimed to investigate the CYP activity in patients with liver cirrhosis with different Child stages (A-C) using the Basel phenotyping cocktail approach.
Leveraging large observational studies to discover genetic determinants of drug concentrations: A proof-of-concept study.
Clin Transl Sci
April 2022
Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
Large, observational genetic studies are commonly used to identify genetic factors associated with diseases and disease-related traits. Such cohorts have not been commonly used to identify genetic predictors of drug dosing or concentrations, perhaps because of the heterogeneity in drug dosing and formulation, and the random timing of blood sampling. We hypothesized that large sample sizes relative to traditional pharmacokinetic studies would compensate for this variability and enable the identification of pharmacogenetic predictors of drug concentrations.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!